Research News and Research

RSS

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients

Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

8 Jan 2010

Time constraints prevent women from attending cervical screening; overcoming practical barriers may maximize screening

While emotional barriers such as embarrassment were thought to be the main reason for not attending, this latest study in the Journal of Medical Screening suggests that practical difficulties may be more important.

8 Jan 2010

MUHC unveils new Lung Cancer Navigation Program

A diagnosis of lung cancer can come as a hard blow. The disease has one of the highest mortality rates of all cancers and the sheer complexity of therapy - often involving radiation, chemotherapy and surgery - can leave patients feeling confused and isolated. To help these patients navigate through the complicated treatment process and medical appointments, the MUHC has unveiled its new Lung Cancer Navigation Program (LCNP).

8 Jan 2010

Senate passes Patient Protection and Affordable Care Act; WHOA included as provision in health reform bill

The United States Senate, in a historic Christmas Eve vote, passed the Patient Protection and Affordable Care Act of 2009 (H.R. 3590). The Women's Health Office Act (WHOA), SWHR's signature piece of legislation, was included as a provision in the health reform bill, marking a tremendous accomplishment for women's health and women's health research and an advancement of SWHR's advocacy work.

8 Jan 2010

Cell Medica signs R&D agreement with the Center for Cell and Gene Therapy

Cell Medica, a clinical cellular therapeutics company developing proven cell therapies which address important unmet clinical needs in oncology and infectious diseases, announced today the signing of an R&D agreement with the Center for Cell and Gene Therapy, a joint program of Baylor College of Medicine, Texas Children’s Hospital and The Methodist Hospital, Houston, Texas.

8 Jan 2010

NEB introduces Lemo21(DE3) Competent E. coli

New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression.

From New England Biolabs 8 Jan 2010

Variants in CRP gene not associated with increased risk of cancer

Gene variants associated with increased circulating levels of C-reactive protein, a marker of inflammation, are not associated with an increased risk of cancer, according to a new brief communication published online January 7 in the Journal of the National Cancer Institute.

8 Jan 2010

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Proteostasis Therapeutics announced today that it has entered into an exclusive license agreement with New York University for intellectual property related to discoveries from the laboratory of David Ron, M.D., Professor of Medicine and Julius Raynes Professor of Cell Biology at NYU Langone Medical Center’s Skirball Institute of Biomolecular Medicine.

8 Jan 2010

Majority of long-term cancer survivors do not have access to personalized care services

An increasing number of people are surviving cancer, but many do not receive the services and support they need in the long term, Macmillan Cancer Support has said.

8 Jan 2010

Findings shed new light on the molecular mechanisms of visual system in brain

The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.

8 Jan 2010

Nation's best cardiac programs team up to offer improved heart care

Mount Sinai Medical Center in Miami Beach is among Florida's most renowned heart hospitals. New York's Columbia University Medical Center is ranked among the nation's top cardiovascular programs. Together, they take the best heart care and make it better for South Florida

8 Jan 2010

UK-based Andromeda Capital invests 1.25 million in TheraSim

TheraSim, Inc., the leading simulation-training company dedicated to providing online tools and solutions to reduce performance errors in healthcare and clinical research, secured a $1.25 million round of investment from UK-based Andromeda Capital.

8 Jan 2010

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.

8 Jan 2010

H1N1 can spread during commercial flights; avoid economy and fly first class, UCLA researchers say

Viruses love plane travel. They get to fly around the world inside a closed container while their infected carrier breathes and coughs, spreading pathogens to other passengers, either by direct contact or through the air. And once people deplane, the virus can spread to other geographical areas.

8 Jan 2010

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

A new national survey reveals that while almost all Canadians understand the importance of getting checked for colon cancer, most have not had a screening test and are confused about how and when it should happen.

8 Jan 2010

Congress approves $1.5 million for first-ever psoriasis patient registry at CDC

Millions of Americans suffering from psoriasis and psoriatic arthritis got a year-end boost from the federal government when it approved $1.5 million for the first-ever psoriasis patient registry at the Centers for Disease Control (CDC).

8 Jan 2010

University of Washington and Aegis Living to promote wellness programs

Healthy aging is more than just a saying at Aegis Living, a national leader in assisted living and Memory Care communities. Now it's working with faculty at University of Washington School of Medicine to make strides in the advancement of healthy aging through collaborative efforts started in Aegis Living's new Living 4 Life® program.

8 Jan 2010

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir’s potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington’s Disease.

8 Jan 2010

Gene modification of human embryonic stem cells may yield potential treatments for genetic diseases

Biologists have developed an efficient way to genetically modify human embryonic stem cells. Their approach, which uses bacterial artificial chromosomes to swap in defective copies of genes, will make possible the rapid development of stem cell lines that can both serve as models for human genetic diseases and as testbeds on which to screen potential treatments, they say.

8 Jan 2010

Breakthrough findings could lead to new treatments for prostate, brain and skin cancers

Researchers at the Lady Davis Institute for Medical Research of the Jewish General Hospital and McGill University in Montreal have discovered a previously unsuspected link between two different genetic pathways which suppress the growth of cancer tumours.

8 Jan 2010

Research News and Research

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients

Time constraints prevent women from attending cervical screening; overcoming practical barriers may maximize screening

MUHC unveils new Lung Cancer Navigation Program

Senate passes Patient Protection and Affordable Care Act; WHOA included as provision in health reform bill

Cell Medica signs R&D agreement with the Center for Cell and Gene Therapy

NEB introduces Lemo21(DE3) Competent E. coli

Variants in CRP gene not associated with increased risk of cancer

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Majority of long-term cancer survivors do not have access to personalized care services

Findings shed new light on the molecular mechanisms of visual system in brain

Nation's best cardiac programs team up to offer improved heart care

UK-based Andromeda Capital invests 1.25 million in TheraSim

Patient enrollment in Tolerx's Phase 3 clinical study DEFEND-1 completed

H1N1 can spread during commercial flights; avoid economy and fly first class, UCLA researchers say

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

Congress approves $1.5 million for first-ever psoriasis patient registry at CDC

University of Washington and Aegis Living to promote wellness programs

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Gene modification of human embryonic stem cells may yield potential treatments for genetic diseases

Breakthrough findings could lead to new treatments for prostate, brain and skin cancers

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News